MedPath
NMPA Approval

Aprepitant Injection

国药准字H20253052

January 2, 2025

Drug Information

阿瑞匹坦注射液

注射剂

18ml:130mg

化学药品

January 2, 2025

Company Information

Applicant Company

成都市新都卫星城工业开发区南二路

Manufacturing Company

四川省成都市新都卫星城工业开发区南二路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿瑞匹坦注射液 - NMPA 批准文号 | MedPath